Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-EN
Language French English
Date Updated 2022-01-04 2021-08-10
Drug Identification Number 02245464 02245464
Brand name BLES BLES
Common or Proper name bovine lipid extract surfactant bovine lipid extract surfactant
Company Name BLES BIOCHEMICALS INC BLES BIOCHEMICALS INC
Ingredients SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C PHOSPHOLIPID SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C PHOSPHOLIPID
Strength(s) 500MCG 27MG 500MCG 27MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRATRACHEAL INTRATRACHEAL INTRATRACHEAL INTRATRACHEAL
Packaging size 4 mL 4 mL
ATC code R07AA R07AA
ATC description OTHER RESPIRATORY SYSTEM PRODUCTS OTHER RESPIRATORY SYSTEM PRODUCTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-12-31 2021-12-31
Actual discontinuation date 2021-12-31
Remaining supply date 2021-12-31 2021-12-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments 3 mL and 5 mL sizes remain available 3 mL and 5 mL sizes remain available
Health Canada comments